Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
𝛼
SK
or Search
SIGN UP
SIGN IN
ENTITY
Cmg Pharmaceutical (058820 KS)
Watchlist
18
Analysis
Health Care
•
South Korea
CMG Pharmaceutical Co., Ltd. develops and markets general pharmaceuticals and healthcare functional pharmaceuticals, and manufactures apparatus used in medical treatments and surgeries.
more
Watchlist
All
Insights
Primers
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bullish
•
Lotte Confectionery
•
16 Nov 2022 20:52
KOSPI 200 & KOSDAQ 150 Rebalance Changes + KOSPI 200 & KOSDAQ 150 Exclusion Candidates in 2023
Korea Exchange announced the KOSPI 200, KOSDAQ 150, and KRX 300 rebalance changes today. Lotte Confectionery will be added and Samyang Holdings...
Douglas Kim
Follow
1k Views
Share
bullish
•
HPSP
•
01 Nov 2022 04:40
KOSDAQ150 Index Rebalance Preview: Big Churn in IT, Healthcare Stocks
There could be 11 changes at the Dec rebalance. Most changes are high probability and will result in a big churn in the IT & Healthcare sectors....
Brian Freitas
Follow
556 Views
Share
bullish
•
ISC Co Ltd
•
07 Oct 2022 06:53
KOSDAQ150 Index Rebalance Preview: Moving in the Right Direction
There could be 10 changes to the KOSDAQ150 Index in December. There are a few stocks that are close adds/deletes. The potential adds have...
Brian Freitas
Follow
658 Views
Share
bullish
•
ISC Co Ltd
•
12 Jul 2022 07:00
KOSDAQ150 Index Rebalance Preview (Dec 2022): Changes Galore Early in the Review Period
One third of the way through the review period, we see 11 potential changes. The potential adds have outperformed the potential deletes and there...
Brian Freitas
Follow
641 Views
Share
bullish
•
GOLFZON
•
27 Mar 2022 15:21
KOSDAQ150 Index Rebalance Preview (June): Potential Inclusions Starting to Outperform
With 80% of the review period complete, there are 15 potential index changes. The potential inclusions have started to outperform the index and the...
Brian Freitas
Follow
663 Views
Share
Previous
1
2
3
4
Next
Last
For Institutional Investors and Financial Services
For Corporate IR and Strategy
For Private Wealth Intermediaries
Pricing
How Smartkarma Compares
Who We Are
Careers
FAQs
Research Provider Solutions
Syndicate your Publications
Compliance
Terms of Use
Privacy Policy
Press Kit
RSS Feeds
Request a Free Trial
Avail a Transition Account
Guest Posts on Smartkarma
Other Enquiries
Join TL;DR Community
Free Weekly Newsletters
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.70.4
x